Andrew Cooper, PhD

Vice President, Global Epidemiology & RWE
Shionogi B.V., United Kingdom

Poster(s):

• (A-102) Addressing methodological challenges in estimating treatment effects using external controls in rare disease clinical trials when controls cross over to open label treatment
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET